 | Up a level |
Number of items: 1.
Pagel, John M., Coutre, Steven E., Furman, Richard R., Sharman, Jeff P., Cheson, Bruce D., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian W., Ghia, Paolo, Eradat, Herbert A., Ervin, Thomas, Lamanna, Nicole 
ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew, Li, Xiaoming, Jahn, Thomas M., O'Brien, Susan M. and Hallek, Michael J.
(2015).
Second Interim Analysis of a Phase 3 Study Evaluating Idelalisib and Rituximab for Relapsed Chronic Lymphocytic Leukemia.
Clin. Lymphoma Myeloma Leuk., 15.
S. S201 - 2.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669